🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Er statsministeren ikke klar over, hvor meget ude af sync med virkeligheden, hun er, med sin appel om at gøre en ekstra indsats, spurgte Yngre Lægers formand, Helga Schultz YL ved Yngre Læger repræsentantskabsmøde. Der er brug for stærke fagforeninger til at sige nok er nok.

Vi søger en bioanalytiker til vores forsknings-lab, så hvis du er eller kender en der er bioanalytiker, så slå endelig til! Filip K. Knop candidate.hr-manager.net/ApplicationIni…

Admirable PhD-defence by Emilie Skytte Andersen ! Clear and calm presentation on gestational diabetes - and clever answers to difficult questions. Congratulations! 🍾🤩🤓 Steno Diabetes Center Copenhagen Tina Vilsbøll Filip K. Knop

STEP-6 Semaglutide 2.4 mg one weekly in PPL with #obesity from Southeast Asia. Body weight still going down at 68 weeks The Lancet Diabetes & Endocrinology thelancet.com/journals/landi…

So the Danish SSI (an agency responsible for disease control and research) has been forced to create an English language page to counter a wave of mis- and disinformation by blue check American Twitter accounts. This is something else! en.ssi.dk/covid-19/typic…

If you’re attending the #ADA2022 (physically or virtually) you’re more than welcome to visit Lærke Smidt Gasbjerg ‘s and my poster about GIP’s effects on lipid uptake in man (an effect lost in T2D) - no. 1362-P ada.apprisor.org/index.cfm?k=yc… Filip K. Knop @signestensen Tina Vilsbøll Mette Rosenkilde ++

Kræftlæge Helga Schultz YL med absurd ‘ønske’: Hvis bare hendes mand havde haft kræft og ikke depression og angst - så havde han fået den behandling og hjælp, han havde brug for… Psykiatrien anno 2022 er kræftområdet anno 2000 #tiårsplanen #sundpol #dkpol information.dk/debat/2022/08/…

FADL blev i sin tid oprettet som ventilatørkorps til poliopatienter. Medicinstuderende har gennem tiden altid været interesserede i - og til tider nødvendige for - at bidrage til et fungerende sundhedsvæsen. Lyt til dem og brug dem! altinget.dk/sundhed/artike…

So nice to be at #EASD2022 in-person. Thanks for the nice update and overview of hba1c targets, Juris Meier & Tina Vilsbøll

Is Tirzepatide renoprotective? Post hoc exploration of secondary endpoints from SURPASS 4 The Lancet Diabetes & Endocrinology thelancet.com/journals/landi…

On my way to Lausanne to learn all about the newest research in #incretins - with great people 🌤 Lærke Smidt Gasbjerg Filip K. Knop HenrietteNerild, and more #EISG22

Great finally to be able to meet good friends and colleagues in the EUROPEAN INCRETIN STUDY GROUP again😊 The best scientific meeting! Thanks to Bernard Thorens for hosting the meeting in beautiful #Lausanne. wp.unil.ch/incretin-study…

Lausanne is great in incretins but capable of much more than that! #thegreatescape Filip K. Knop Maria Ebbesen Sørum #eisg22 🤓🍻

In this #RCT, Mads M. Helsted investigates the effects of 6-week s.c. GIP or placebo infusion added to once-weekly s.c. 0.5 mg semaglutide or placebo. Powered to detect clinical relevant changes in CGM-assessed mean glucose. + several exploratory endpoints. bmjopen.bmj.com/content/13/2/e…

Strong data on @ZealandPharma's dasiglucagon as a treatmet for postbariatric postprandial hypoglycaemia beautifully presented at Advanced Technologies & Treatments for Diabetes in Berlin by Casper Nielsen Full presentation via this link: attd.kenes.com/virtual-login/ Trial design via this link: beta.clinicaltrials.gov/study/NCT04836…

Semaglutide 2.4 mg reduces the risk of major adverse cardiovascular events by 20% in adults with overweight or obesity in the SELECT trial🤩 (n=17,604 adults aged >44 years with overweight or obesity and established CVD with no prior history of diabetes) novonordisk.com/content/nncorp…